{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:32:26Z","timestamp":1777494746726,"version":"3.51.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea","award":["A121776"],"award-info":[{"award-number":["A121776"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.clinbiochem.2014.05.002","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T10:34:14Z","timestamp":1400063654000},"page":"1257-1261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma"],"prefix":"10.1016","volume":"47","author":[{"given":"Choong-Kyun","family":"Noh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyo Jung","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun A","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Jeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Joong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joo An","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seun Joo","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Jae","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kee Myung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Moo","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Won","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Youn","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocan 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0010","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(98)09148-X","article-title":"Hepatocellular carcinoma","volume":"353","author":"Schafer","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0015","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int. J. cancer"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0020","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"American Association for the Study of Liver D. Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0025","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0030","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/0167-4838(94)90122-8","article-title":"Purification and characterization of a novel substrate for plasma kallikrein (pk-120) in human plasma","volume":"1208","author":"Pu","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/dvdy.1235","article-title":"ITIH-4, a serine protease inhibitor regulated in interleukin-6-dependent liver formation: role in liver development and regeneration","volume":"223","author":"Bhanumathy","year":"2002","journal-title":"Dev Dyn"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0040","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/elps.200700828","article-title":"Lectin-based electrophoretic analysis of the expression of the 35 kda inter-alpha-trypsin inhibitor heavy chain H4 fragment in sera of patients with five different malignancies","volume":"29","author":"Mohamed","year":"2008","journal-title":"Electrophoresis"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0045","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1158\/1078-0432.1110.11.3","article-title":"Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins","volume":"11","author":"Koomen","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0050","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/sj.onc.1209281","article-title":"Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production","volume":"25","author":"Ogata","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0055","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1373\/clinchem.2005.065722","article-title":"Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption\/ionization-based immunoassay","volume":"52","author":"Song","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0060","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1073\/pnas.0705395105","article-title":"Progenitor\/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling","volume":"105","author":"Tang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-8278(99)80173-1","article-title":"A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'etude et de traitement du carcinome hepatocellulaire","volume":"31","author":"Chevret","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0070","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/1097-0142(19891015)64:8<1700::AID-CNCR2820640824>3.0.CO;2-Z","article-title":"Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients","volume":"64","author":"Nomura","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0075","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/cncr.10384","article-title":"Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients","volume":"94","author":"Leung","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI26022","article-title":"Differential exoprotease activities confer tumor-specific serum peptidome patterns","volume":"116","author":"Villanueva","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0085","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ijc.20928","article-title":"Classification of cancer types by measuring variants of host response proteins using SELDI serum assays","volume":"115","author":"Fung","year":"2005","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0090","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/rcm.4588","article-title":"Sensitive liquid chromatography\/tandem mass spectrometry assay for absolute quantification of ITIH4-derived putative biomarker peptides in clinical serum samples","volume":"24","author":"van den Broek","year":"2010","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/j.clinbiochem.2014.05.002_bb0095","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1158\/0008-5472.CAN-04-0746","article-title":"Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer","volume":"64","author":"Zhang","year":"2004","journal-title":"Cancer Res"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014002227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912014002227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:43:26Z","timestamp":1757864606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912014002227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":19,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0009912014002227"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.05.002","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2014.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}